CAMBRIDGE, Massachusetts, May 20, 2013 /PRNewswire/ --
Genomics Data App now available in BaseSpace Apps
Elsevier, a world-leading provider of scientific, medical and technical products and services, announces the launch of the Genomics Data app in collaboration with Illumina, a sequencing and array-based solutions provider for genetics research.
The app allows researchers to share large data sets in Illumina's BaseSpace cloud, where they can easily be reviewed and included in Elsevier's open access journal, Genomics Data . The BaseSpace app serves as a gateway, opening data stored in the cloud to the publishing environment for expert peer review and wide dissemination in the form of a professional publication."In genomic studies we often generate large data sets of tremendous value. Without a means to publish these data sets and get credit for them, they easily get lost," said John Quackenbush, Co-Editor-in-Chief of Genomics Data. "By working together with Illumina to develop a reviewing pipeline from BaseSpace to Genomics Data, we've created a simple way for researchers to make genomic data accessible to publication in a journal." Through BaseSpace, authors and reviewers will also have additional access to analytical tools, further enhancing Genomics Data ' s peer review process. This enhanced review option can give an article attached to the data set added credibility because reviewers are in the position to reproduce the analysis that the authors did. "Uploading genomic data to BaseSpace has reached critical mass. The innovative development of the Genomics Data App demonstrates how Elsevier is able to create new and unique opportunities for researcher collaboration," said Alex Dickinson, Senior Vice President, Cloud Genomics at Illumina. To view the app, please register for free on:
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts